- Telehealth Visits
- Insurance plan information
Brett Dietz, MD, MS
He | Him | HisRheumatology- Telehealth Visits
- Insurance plan information
Brett Dietz, MD, MS
He | Him | HisRheumatology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Brett Dietz is a rheumatologist who cares for patients with a wide range of arthritic and autoimmune disorders, including gout, rheumatoid arthritis, lupus, sarcoidosis, myositis and vasculitis. In addition to patient care, he has an interest in contributing to the education of medical students, residents and fellows.
Dietz earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed a residency in internal medicine and a fellowship in rheumatology at UCSF.
Education & training
Board certification
- Rheumatology, American Board of Internal Medicine/Rheumatology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Rheumatology, UCSF Cardiology Fellowship-GME
Residency
- Internal Medicine, UCSF Cardiology Fellowship-GME
Degree
- MD, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania
My expertise
Specialties
Conditions
Locations
My research
Publications
Showing 1-6 of 51 reviews
- March 30, 20265 out of 5 Stars
Dr. Dietz is terrific!
- February 3, 20265 out of 5 Stars
5 star physician!
- January 14, 20265 out of 5 Stars
I can't imagine being any happier with this entire visit and my interactions with Dr Dietz
- January 5, 20265 out of 5 Stars
Highly recommend the doctor
- December 22, 20255 out of 5 Stars
Dr. Dietz is a wonderful physician, he is always very informative, listens well and is caring. His treatment plan for me has been successful so far, lucky to have him as my Doctor!
- December 15, 20255 out of 5 Stars
Everything was excellent
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.